The
Gynecologic Oncology Group
("GOG") is a national organization dedicated to clinical
research in the field of gynecologic cancer. It is one of the
cooperative clinical trial research groups funded by the
National Cancer Institute (NCI). The purpose and mission of the
GOG is to improve and expand the treatment of gynecologic
cancer. These goals are met through an exchange of information
on programs of study, teaching methods and research activities
among gynecologic oncologists, medical oncologists, radiation
oncologists, nurse oncologists, pathologists, and basic
scientists.
What is the Industry Collaboration Team?
The ICT is a new and exciting
membership program designed and developed by the GOG to foster
and facilitate a two-way communication channel between Industry
and the GOG. The GOG strives to build a strong partnership with
industry in order to serve as their research and collaboration
partner, paving the way for advancement in the field of
Gynecologic Oncology.
Specifically, the ICT:
·
Provides for a
more rapid accumulation of information for pooling knowledge by
multidiscipline organizations and industry.
·
Fosters
interaction between leaders in oncology and industry.
·
Provides
visibility to market products and services to professionals in
decision-makings roles.
·
Provides an
opportunity to extend new information to attendees of new and
improving technologies, equipment, products, and services.
·
Complementary
welcome event with GOG Leadership.
·
Three corporate
representatives from each organization will give your
organization greater exposure.
·
Roster mailing
labels upon request.
·
Corporate
information with company profile displayed under the “ICT” link
on the GOG website. This allows a direct link with your
corporation.
·
Opportunity to
host your own Advisory Board during the GOG Functions.
Click Here for an ICT Enrollment
Form
